Comparing Pediatric and Adult Primary Chest Wall Tumors
1Department of Thoracic Surgery, Ankara Atatürk Sanatorium Training and Research Hospital, Ankara, Türkiye
2Department of Thoracic Surgery, Faculty of Medicine, University of Erciyes, Kayseri, Türkiye
3Department of Pediatrics, Division of Pediatric Hematology Oncology Unit, Faculty of Medicine, University of Erciyes, Kayseri, Türkiye
4Department of Anesthesiology and Reanimation, Faculty of Medicine, University of Erciyes, Kayseri, Türkiye
5Department of Respiratory Medicine, Faculty of Medicine, University of Erciyes, Kayseri, Türkiye
6Department of Pediatric Pulmonology, Faculty of Medicine, University of Erciyes, Kayseri, Türkiye
J Clin Pract Res 2023; 45(6): 624-631 DOI: 10.14744/cpr.2023.07279
Full Text PDF

Abstract

Objective: This study aims to evaluate the differences in surgical interventions and out-comes for primary chest wall tumors in pediatric and adult patient groups.
Materials and Methods: We reviewed records of patients operated on for primary chest wall tumors from January 2005 to June 2019. Patients aged 18 and younger were classified as pediatric (group I), while those above 18 were considered adults (group II). We analyzed demographic characteristics, histopathologic diagnosis, number of resected ribs, prosthet-ics requirements, complications, chemotherapy and radiotherapy applications, and related complications. The Kaplan-Meier method was used to analyze patient survival times, and the log-rank test was employed for comparing survival times between groups.
Results: Of the 71 patients who underwent operations for primary chest wall tumors in our clinic between January 2005 and June 2019, 20 were pediatric (28.2%) and 51 were adults (71.8%). The 5-year overall survival rates for pediatric and adult patients were 72.9% and 68.8%, respectively (p=0.683), while the 5-year disease-free survival rates were 76.0% and 69.0%, respectively, showing no significant differences (p=0.709).
Conclusion: Our findings indicate no significant differences between pediatric and adult primary chest wall tumors regarding disease-free survival times, overall survival rates, and surgical complications.